- Shares of Centene (NYSE: CNC) fell today alongside other managed-care names after President Trump urged redirecting Affordable Care Act (ACA) subsidies away from insurers; Reuters cited ~7% premarket pressure for CNC. [1]
- Centene issued two expansion press releases this morning:
Market snapshot
As of 14:48 UTC on Nov. 10, CNC traded at $33.91 (intraday range $33.64–$36.09).
Why CNC is under pressure today
In posts over the weekend, President Donald Trump called for redirecting “hundreds of billions” in ACA subsidy funds directly to consumers, rather than to insurers. By early Monday, managed-care stocks with ACA exposure, including Centene, were lower in premarket trading. Reuters notes the comments land amid a 40‑day federal government shutdown and renewed debate over enhanced ACA subsidies set to expire Dec. 31, a program that has helped double ACA enrollment to ~24 million since 2021. [4]
Company announcements (Nov. 10, 2025)
1) Wellcare broadens Texas Medicare footprint for 2026
Time: 9:00 a.m. ET
What’s new:Wellcare (Centene’s Medicare brand) said it will offer MA and Part D plans in 205 Texas counties in 2026, including major metros (Austin, Dallas, El Paso, Houston, San Antonio). The release highlights a first-phase rollout of an enhanced integrated D‑SNP model (administering both Medicare and Medicaid benefits) in Dallas and Hidalgo counties, as the industry transitions from MMPs to integrated D‑SNPs on Jan. 1, 2026. Wellcare says its 2026 MA/PDP lineup spans 32 states and 1,850+ counties, reaching 51M+ eligible beneficiaries, with features such as the Wellcare Spendables® card and $0 PCP copays on all plans. Medicare AEP runs Oct. 15–Dec. 7, 2025 (coverage effective Jan. 1, 2026). [5]
2) Ambetter launches 2026 Marketplace plans statewide in South Carolina
Time: 8:01 a.m. ET
What’s new:Ambetter from Absolute Total Care will offer ACA Marketplace plans statewide in South Carolina for plan year 2026. Marketplace open enrollment runs Nov. 1, 2025–Jan. 15, 2026; enroll by Dec. 15 for Jan. 1 coverage. The release spotlights Virtual 24/7 Care, My Health Pays® rewards up to $500 for qualifying activities, and Ambetter Health Solutions (off‑exchange products compatible with ICHRAs) available in select states, including South Carolina. [6]
Today’s Centene news timeline (ET)
• 8:01 a.m. – Ambetter SC statewide 2026 plans announced.
• 9:00 a.m. – Wellcare Texas 2026 MA/PDP expansion announced.
(Source: Centene press room.) [7]
Context: Where fundamentals stand after Q3
Late last month, Centene raised its 2025 adjusted EPS outlook to at least $2.00 and said it expects to grow adjusted EPS in 2026, after posting Q3 adjusted EPS of $0.50 on revenue of ~$49.7B (+18% Y/Y). The quarter also included a $6.7B non‑cash goodwill impairment, producing a GAAP loss but tied primarily to anticipated policy changes beyond 2025. Shares rallied on the beat and outlook at the time. [8]
What it means
- Policy overhang vs. growth initiatives: Today’s selloff underscores how ACA‑subsidy policy risk can overshadow near‑term footprint expansion (Wellcare MA/PDP; Ambetter Marketplace) and recent operating progress in Medicaid. Centene remains among the most ACA‑exposed national payers, making it more sensitive to headlines around enhanced subsidy renewal and risk‑adjustment dynamics. [9]
- Medicare and D‑SNP strategy: The Texas D‑SNP integration and broad MA/PDP coverage reflect Centene’s push to better coordinate care for dual‑eligible members, an area that can improve retention and quality metrics but requires careful execution and state‑federal alignment. [10]
Key dates consumers should know
- Medicare AEP (for 2026 coverage):Oct. 15–Dec. 7, 2025 (enroll by Dec. 7 for Jan. 1, 2026 effective date). Texas beneficiaries can compare Wellcare options during this window. [11]
- ACA Marketplace open enrollment (for 2026 coverage):Nov. 1, 2025–Jan. 15, 2026 (enroll by Dec. 15 for Jan. 1, 2026 start). South Carolina residents can view Ambetter plans now. [12]
Bottom line for investors
Today (Nov. 10, 2025) brought two expansion releases from Centene plus a macro-policy shock that weighed on the stock. The debate over enhanced ACA subsidies remains the single largest external swing factor for ACA‑centric insurers heading into 2026 rate‑setting and enrollment — even as Centene signals EPS growth ambitions for 2026 and invests in Medicare/D‑SNP integration. Keep an eye on Congress’s path on subsidy renewal and Centene’s February guidance update for clearer visibility into next year’s earnings trajectory. [13]
This article is for informational purposes only and is not investment advice. All plan features and eligibility vary by state and product; consult official plan documents for details.
References
1. www.reuters.com, 2. investors.centene.com, 3. investors.centene.com, 4. www.reuters.com, 5. investors.centene.com, 6. investors.centene.com, 7. investors.centene.com, 8. www.reuters.com, 9. www.reuters.com, 10. investors.centene.com, 11. investors.centene.com, 12. investors.centene.com, 13. www.reuters.com
